Persistent Inhibition of ABL Tyrosine Kinase Causes Enhanced Apoptotic Response to TRAIL and Disrupts the Pro-Apoptotic Effect of Chloroquine

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sridevi, Priya ^a   Nhiayi, May K ^a   Setten, Ryan L ^a   Wang, Jean Y J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CHLOROQUINE; DOXORUBICIN; IMATINIB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER THERAPY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIZATION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; FOOD AND DRUG ADMINISTRATION; GENE SILENCING; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; LYSOSOME; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; UBIQUITINATION;

APOPTOSIS; CASPASE 8; CELL LINE; CELL NUCLEUS; CHLOROQUINE; ENZYME ACTIVATION; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYSOSOMES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-ABL; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UBIQUITINATION;

EID: 84885393965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077495     Document Type: Article

References (69)

1. Ashkenazi A, Holland P, Eckhardt SG, (2008) Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 26: 3621-3630. doi:10.1200/JCO.2007.15.7198. PubMed: 18640940.
2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104: 155-162. doi:10.1172/JCI6926. PubMed: 10411544.
3. Ozören N, Fisher MJ, Kim K, Liu CX, Genin A, et al. (2000) Homozygous deletion of the death receptor DR4 gene in a nasopharyngeal cancer cell line is associated with TRAIL resistance. Int J Oncol 16: 917-925. PubMed: 10762627.
4. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, et al. (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-821. doi:10.1126/science.277.5327.818. PubMed: 9242611.
5. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, et al. (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61: 1314-1319. PubMed: 11245427.
6. French LE, Tschopp J, (1999) Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J Exp Med 190: 891-894. doi:10.1084/jem.190.7.891. PubMed: 10510078.
7. Fulda S, Meyer E, Debatin KM, (2002) Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21: 2283-2294. doi:10.1038/sj.onc.1205258. PubMed: 11948412.
8. Ehrhardt H, Fulda S, Schmid I, Hiscott J, Debatin KM, et al. (2003) TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-kappaB. Oncogene 22: 3842-3852. doi:10.1038/sj.onc.1206520. PubMed: 12813457.
9. Russo M, Mupo A, Spagnuolo C, Russo GL, (2010) Exploring death receptor pathways as selective targets in cancer therapy. Biochem Pharmacol 80: 674-682. doi:10.1016/j.bcp.2010.03.011. PubMed: 20302848.
10. Galligan L, Longley DB, McEwan M, Wilson TR, McLaughlin K, et al. (2005) Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP. Mol Cancer Ther 4: 2026-2036. doi:10.1158/1535-7163.MCT-05-0262. PubMed: 16373718.
11. Lacour S, Micheau O, Hammann A, Drouineaud V, Tschopp J, et al. (2003) Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells. Oncogene 22: 1807-1816. doi:10.1038/sj.onc.1206127. PubMed: 12660816.
12. Zhao B, Li L, Cui K, Wang CL, Wang AL, et al. (2011) Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Asian Pac J Cancer Prev 12: 2675-2678. PubMed: 22320973.
13. Xu J, Zhou JY, Wu GS, (2006) Tumor necrosis factor-related apoptosis-inducing ligand is required for tumor necrosis factor alpha-mediated sensitization of human breast cancer cells to chemotherapy. Cancer Res 66: 10092-10099. doi:10.1158/0008-5472.CAN-06-1633. PubMed: 17047073.
14. Kelly MM, Hoel BD, Voelkel-Johnson C, (2002) Doxorubicin pretreatment sensitizes prostate cancer cell lines to TRAIL induced apoptosis which correlates with the loss of c-FLIP expression. Cancer Biol Ther 1: 520-527. doi:10.4161/cbt.1.5.174. PubMed: 12496481.
15. Chau BN, Chen TT, Wan YY, DeGregori J, Wang JY, (2004) Tumor necrosis factor alpha-induced apoptosis requires p73 and c-ABL activation downstream of RB degradation. Mol Cell Biol 24: 4438-4447. doi:10.1128/MCB.24.10.4438-4447.2004. PubMed: 15121862.
16. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin WG Jr., et al. (1999) The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399: 806-809. doi:10.1038/21690. PubMed: 10391249.
17. Preyer M, Shu CW, Wang JY, (2007) Delayed activation of Bax by DNA damage in embryonic stem cells with knock-in mutations of the Abl nuclear localization signals. Cell Death Differ 14: 1139-1148. doi:10.1038/sj.cdd.4402119. PubMed: 17363963.
18. Shaul Y, (2000) c-Abl: activation and nuclear targets. Cell Death Differ 7: 10-16. doi:10.1038/sj.cdd.4400626. PubMed: 10713716.
19. Sridevi P, Nhiayi MK, Wang JY, (2013) Genetic disruption of Abl nuclear import reduces renal apoptosis in a mouse model of cisplatin-induced nephrotoxicity. Cell Death Differ 20: 953-962. doi:10.1038/cdd.2013.42. PubMed: 23660976.
20. Wang JY, (2005) Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress. Cell Res 15: 43-48. doi:10.1038/sj.cr.7290263. PubMed: 15686626.
21. Zhu J, Wang JY, (2004) Death by Abl: a matter of location. Curr Top Dev Biol 59: 165-192. doi:10.1016/S0070-2153(04)59007-5. PubMed: 14975251.
22. Wang JY, (2000) Regulation of cell death by the Abl tyrosine kinase. Oncogene 19: 5643-5650. doi:10.1038/sj.onc.1203878. PubMed: 11114745.
23. Solier S, Kohn KW, Scroggins B, Xu W, Trepel J, et al. (2012) Heat shock protein 90alpha (HSP90alpha), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc Natl Acad Sci U S A 109: 12866-12872. doi:10.1073/pnas.1203617109. PubMed: 22753480.
24. Solier S, Sordet O, Kohn KW, Pommier Y, (2009) Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways. Mol Cell Biol 29: 68-82. doi:10.1128/MCB.00581-08. PubMed: 18955500.
25. Huang DY, Chao Y, Tai MH, Yu YH, Lin WW, (2012) STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. J Biomed Sci 19: 35. doi:10.1186/1423-0127-19-35. PubMed: 22462553.
26. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC, (1991) Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65: 1153-1163. doi:10.1016/0092-8674(91)90011-M. PubMed: 2065352.
27. Azam M, Latek RR, Daley GQ, (2003) Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112: 831-843. doi:10.1016/S0092-8674(03)00190-9. PubMed: 12654249.
28. Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, et al. (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112: 859-871. doi:10.1016/S0092-8674(03)00194-6. PubMed: 12654251.
29. Taagepera S, McDonald D, Loeb JE, Whitaker LL, McElroy AK, et al. (1998) Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc Natl Acad Sci U S A 95: 7457-7462. doi:10.1073/pnas.95.13.7457. PubMed: 9636171.
30. Wen ST, Jackson PK, Van Etten RA, (1996) The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J 15: 1583-1595. PubMed: 8612582.
31. Lewis JM, Baskaran R, Taagepera S, Schwartz MA, Wang JY, (1996) Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport. Proc Natl Acad Sci U S A 93: 15174-15179. doi:10.1073/pnas.93.26.15174. PubMed: 8986783.
32. Yoshida K, Yamaguchi T, Natsume T, Kufe D, Miki Y, (2005) JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nat Cell Biol 7: 278-285. doi:10.1038/ncb1228. PubMed: 15696159.
33. Burton EA, Plattner R, Pendergast AM, (2003) Abl tyrosine kinases are required for infection by Shigella flexneri. EMBO J 22: 5471-5479. doi:10.1093/emboj/cdg512. PubMed: 14532119.
34. Huang X, Wu D, Jin H, Stupack D, Wang JY, (2008) Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling. J Cell Biol 183: 711-723. doi:10.1083/jcb.200801192. PubMed: 19001122.
35. Jin H, Wang JY, (2007) Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin. Mol Cell Biol 18: 4143-4154. doi:10.1091/mbc.E07-01-0085. PubMed: 17686996.
36. Tanos B, Pendergast AM, (2006) Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor. J Biol Chem 281: 32714-32723. doi:10.1074/jbc.M603126200. PubMed: 16943190.
37. Woodring PJ, Hunter T, Wang JY, (2003) Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci 116: 2613-2626. doi:10.1242/jcs.00622. PubMed: 12775773.
38. Wang JY, Cho SK, (2004) Coordination of repair, checkpoint, and cell death responses to DNA damage. Adv Protein Chem 69: 101-135. doi:10.1016/S0065-3233(04)69004-8. PubMed: 15588841.
39. Gonfloni S, Di Tella L, Caldarola S, Cannata SM, Klinger FG, et al. (2009) Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med 15: 1179-1185. doi:10.1038/nm.2033. PubMed: 19783996.
40. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, et al. (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031-1037. doi:10.1056/NEJM200104053441401. PubMed: 11287972.
41. Hantschel O, Rix U, Superti-Furga G, (2008) Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leuk Lymphoma 49: 615-619. doi:10.1080/10428190801896103. PubMed: 18398720.
42. Jabbour E, Cortes J, Kantarjian H, (2010) Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review. Core Evid 4: 207-213. PubMed: 20694077.
43. Olivieri A, Manzione L, (2007) Dasatinib: a new step in molecular target therapy. Ann Oncol 18 (Suppl 6):: vi42-vi46. doi:10.1093/annonc/mdm223. PubMed: 17591830.
44. Levy D, Adamovich Y, Reuven N, Shaul Y, (2008) Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 29: 350-361. doi:10.1016/j.molcel.2007.12.022. PubMed: 18280240.
45. Raina D, Ahmad R, Kumar S, Ren J, Yoshida K, et al. (2006) MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J 25: 3774-3783. doi:10.1038/sj.emboj.7601263. PubMed: 16888623.
46. Bonnekoh B, Wevers A, Jugert F, Merk H, Mahrle G, (1989) Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res 281: 487-490. doi:10.1007/BF00510085. PubMed: 2482013.
47. Welch PJ, Wang JY, (1995) Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and-independent mechanisms. Mol Cell Biol 15: 5542-5551. PubMed: 7565706.
48. Echarri A, Pendergast AM, (2001) Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr Biol 11: 1759-1765. doi:10.1016/S0960-9822(01)00538-3. PubMed: 11719217.
49. Gonzalvez F, Lawrence D, Yang B, Yee S, Pitti R, et al. (2012) TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. Mol Cell 48: 888-899. doi:10.1016/j.molcel.2012.09.031. PubMed: 23142077.
50. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, et al. (2009) Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137: 721-735. doi:10.1016/j.cell.2009.03.015. PubMed: 19427028.
51. Pan JA, Ullman E, Dou Z, Zong WX, (2011) Inhibition of protein degradation induces apoptosis through a microtubule-associated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes. Mol Cell Biol 31: 3158-3170. doi:10.1128/MCB.05460-11. PubMed: 21628531.
52. Ullman E, Pan JA, Zong WX, (2011) Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury. Mol Cell Biol 31: 2902-2919. doi:10.1128/MCB.05452-11. PubMed: 21576355.
53. Bowman EJ, Siebers A, Altendorf K, (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85: 7972-7976. doi:10.1073/pnas.85.21.7972. PubMed: 2973058.
54. Veignie E, Moreau S, (1991) The mode of action of chloroquine. Non-weak base properties of 4-aminoquinolines and antimalarial effects on strains of Plasmodium. Ann Trop Med Parasitol 85: 229-237. PubMed: 1796865.
55. Baskaran R, Wood LD, Whitaker LL, Canman CE, Morgan SE, et al. (1997) Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387: 516-519. doi:10.1038/387516a0. PubMed: 9168116.
56. Zandy NL, Pendergast AM, (2008) Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases. Cell Cycle 7: 444-448. doi:10.4161/cc.7.4.5452. PubMed: 18235247.
57. Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, et al. (2010) Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function. Proc Natl Acad Sci U S A 107: 16691-16696. doi:10.1073/pnas.1006083107. PubMed: 20823226.
58. Jiang Z, Kamath R, Jin S, Balasubramani M, Pandita TK, et al. (2011) Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl. Mol Cancer 10: 88. doi:10.1158/1535-7163.TARG-11-B88. PubMed: 21781306.
59. Kaidi A, Jackson SP, (2013) KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature 498: 70-74. doi:10.1038/nature12201. PubMed: 23708966.
60. Wilson NS, Dixit V, Ashkenazi A, (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 10: 348-355. doi:10.1038/nrg2602. PubMed: 19295631.
61. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, et al. (1995) Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 376: 785-788. doi:10.1038/376785a0. PubMed: 7651539.
62. Nehmé A, Baskaran R, Aebi S, Fink D, Nebel S, et al. (1997) Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and-deficient cells exposed to cisplatin. Cancer Res 57: 3253-3257. PubMed: 9242457.
63. Baskaran R, Chiang GG, Mysliwiec T, Kruh GD, Wang JY, (1997) Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product. J Biol Chem 272: 18905-18909. doi:10.1074/jbc.272.30.18905. PubMed: 9228069.
64. Baskaran R, Chiang GG, Wang JY, (1996) Identification of a binding site in c-Ab1 tyrosine kinase for the C-terminal repeated domain of RNA polymerase II. Mol Cell Biol 16: 3361-3369. PubMed: 8668151.
65. Baskaran R, Dahmus ME, Wang JY, (1993) Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci U S A 90: 11167-11171. doi:10.1073/pnas.90.23.11167. PubMed: 7504297.
66. Yuan ZM, Huang Y, Fan MM, Sawyers C, Kharbanda S, et al. (1996) Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. J Biol Chem 271: 26457-26460. doi:10.1074/jbc.271.43.26457. PubMed: 8900110.
67. Sionov RV, Moallem E, Berger M, Kazaz A, Gerlitz O, et al. (1999) c-Abl neutralizes the inhibitory effect of Mdm2 on p53. J Biol Chem 274: 8371-8374. doi:10.1074/jbc.274.13.8371. PubMed: 10085066.
68. Zuckerman V, Lenos K, Popowicz GM, Silberman I, Grossman T, et al. (2009) c-Abl phosphorylates Hdmx and regulates its interaction with p53. J Biol Chem 284: 4031-4039. PubMed: 19075013.
69. Yogalingam G, Pendergast AM, (2008) Abl kinases regulate autophagy by promoting the trafficking and function of lysosomal components. J Biol Chem 283: 35941-35953. doi:10.1074/jbc.M804543200. PubMed: 18945674.